Stigma and optimism in adolescents and young adults with cystic fibrosis  Kendea N. Oliver, Matthew L. Free, Cody Bok, Karen S. McCoy, Kathleen L. Lemanek,

Slides:



Advertisements
Similar presentations
Cheryl Cameron, Mark W. Lodes, William M. Gershan 
Advertisements

Ian D. Molyneux, Tanya Moon, A. Kevin Webb, Alyn H. Morice 
The prevalence of “risky behaviour” in adults with cystic fibrosis
Treatment compliance in children and adults with Cystic Fibrosis
Efficacy and safety of ivacaftor in patients with cystic fibrosis and a non-G551D gating mutation  Kris De Boeck, Anne Munck, Seth Walker, Albert Faro,
Long-term follow-up of cystic fibrosis newborn screening: Psychosocial functioning of adolescents and young adults  Audrey Tluczek, Anita Laxova, Adam.
Development, validation, and implementation of a questionnaire assessing disease knowledge and understanding in adult cystic fibrosis patients  Karen.
Towards an individualized protocol for workload increments in cardiopulmonary exercise testing in children and adolescents with cystic fibrosis  H.J.
R. Roberts, L. Speight, J. Lee, L. George, R. I. Ketchell, D. Lau, J
How does heart rate recovery after sub-maximal exercise correlate with maximal exercise testing in children with CF?  Sarah P. Cohen, David M. Orenstein 
Avani C. Modi, Crystal S. Lim, Nami Yu, David Geller, Mary H
Megan R. Nelson, Craig R. Adamski, Audrey Tluczek 
Urinary incontinence in 9���16��year olds with cystic fibrosis compared to other respiratory conditions and a normal group  W.J. Browne, C.J. Wood, M.
Measures of body habitus are associated with lung function in adults with cystic fibrosis: A population-based study  Doug L. Forrester, Alan J. Knox,
Efficacy and safety of ivacaftor in patients with cystic fibrosis and a non-G551D gating mutation  Kris De Boeck, Anne Munck, Seth Walker, Albert Faro,
Microbiological yield from induced sputum compared to oropharyngeal swab in young children with cystic fibrosis  Marco Zampoli, Komala Pillay, Henri Carrara,
Laura Viviani, Baroukh M. Assael, Eitan Kerem 
Cirrhosis and other liver disease in cystic fibrosis
Rate of improvement of CF life expectancy exceeds that of general population— Observational death registration study  Matthew N. Hurley, Tricia M. McKeever,
Computed tomography correlates with improvement with ivacaftor in cystic fibrosis patients with G551D mutation  Shahid I. Sheikh, Frederick R. Long, Karen.
Controlled clinical trials in cystic fibrosis — are we doing better?
Anju Anand, Elizabeth Tullis, Anne Stephenson, Preyanka Abhyankar 
D. Stevens, P.J. Oades, N. Armstrong, C.A. Williams 
Claire J. Tipping, Rebecca L. Scholes, Narelle S. Cox 
Cystic fibrosis mortality trend in Italy from 1970 to 2011
Gerd Döring, Patrick Flume, Harry Heijerman, J. Stuart Elborn 
The Journal of Cystic Fibrosis: Sunny perspectives
Amyloidosis in cystic fibrosis: A case series
Spontaneous coronary artery dissection associated with coughing
Thomas Radtke, Milo A. Puhan, Helge Hebestreit, Susi Kriemler 
Ghrelin and leptin levels in young adults with cystic fibrosis: Relationship with body fat  Charilaos Stylianou, Assimina Galli-Tsinopoulou, George Koliakos,
A.H. Gifford  Journal of Cystic Fibrosis 
Treatment of resistant distal intestinal obstruction syndrome with a modified antegrade continence enema procedure  I.J. Clifton, A.M. Morton, N.S. Ambrose,
Initial evaluation of the Parent Cystic Fibrosis Questionnaire—Revised (CFQ-R) in infants and young children  Adrianne N. Alpern, Lyndia C. Brumback,
Predicting hypoxia in cystic fibrosis patients during exposure to high altitudes  Wolfgang Kamin, Birthe Fleck, Dirk-Mathias Rose, Oliver Thews, Wolfgang.
Inhalation solutions — Which ones may be mixed
Antonia V. Bennett, Donald L. Patrick, James F. Lymp, Todd C
Elisabeth P. Dellon, Elaine Chen, Jessica Goggin, Karen Homa, Bruce C
E. Tschiedel, H. Grasemann, F. Ratjen  Journal of Cystic Fibrosis 
Colon Cancer in Cystic Fibrosis patients: Is this a growing problem?
Depression and anxiety in adolescents and adults with cystic fibrosis in the UK: A cross- sectional study  Alistair J.A. Duff, Janice Abbott, Carolyn Cowperthwaite,
Prevalence and risk factors for recovery of filamentous fungi in individuals with cystic fibrosis  Christopher R. Sudfeld, Elliott C. Dasenbrook, William.
Cytokine gene polymorphisms and severity of CF lung disease
Narelle S. Cox, Jennifer Follett, Karen O. McKay 
Novel concepts in evaluating antimicrobial therapy for bacterial lung infections in patients with cystic fibrosis  Geraint B. Rogers, Lucas R. Hoffman,
Nutritional decline in cystic fibrosis related diabetes: The effect of intensive nutritional intervention  H. White, K. Pollard, C. Etherington, I. Clifton,
Gender differences in treatment adherence among youth with cystic fibrosis: Development of a new questionnaire  Joän M. Patterson, Melanie Wall, Jerica.
Segregation of children with CF diagnosed via newborn screening and acquisition of Pseudomonas aeruginosa  Karen O. McKay, Peter J. Cooper, Peter P. van.
Respiratory pathogens mediate the association between lung function and temperature in cystic fibrosis  Joseph M. Collaco, Karen S. Raraigh, Lawrence.
Higher risk of hospitalization among females with cystic fibrosis
Trends in pathogens colonising the respiratory tract of adult patients with cystic fibrosis, 1985–2005  F.A. Millar, N.J. Simmonds, M.E. Hodson  Journal.
V. Thompson, N. Mayer-Hamblett, M. Kloster, D. Bilton, P.A. Flume 
H. White, A.M. Morton, S.P. Conway, D.G. Peckham 
J.E. Spahr, R.B. Love, M. Francois, K. Radford, K.C. Meyer 
Daniel J. Smith, Gregory J. Anderson, Scott C. Bell, David W. Reid 
Voriconazole therapy in children with cystic fibrosis
D.F. Waterhouse, A.M. McLaughlin, C.G. Gallagher 
The role of respiratory viruses in adult patients with cystic fibrosis receiving intravenous antibiotics for a pulmonary exacerbation  C. Etherington,
CFTR modulators and pregnancy: Our work has only just begun
‘Peeling paint’ dermatitis as a presenting sign of cystic fibrosis
L. Nshimyumukiza, A. Bois, P. Daigneault, L. Lands, A. -M. Laberge, D
Beta-lactam allergy in adults with cystic fibrosis
Cheryl Cameron, Mark W. Lodes, William M. Gershan 
Lutz Goldbeck, Sven Zerrer, Tim G. Schmitz  Journal of Cystic Fibrosis 
Khin M. Gyi, Margaret E. Hodson, Magdi Y. Yacoub 
David Adeboyeku, Sandra Scott, Margaret E. Hodson 
Increasing resistance of the Liverpool Epidemic Strain (LES) of Pseudomonas aeruginosa (Psa) to antibiotics in cystic fibrosis (CF)—A cause for concern? 
Elisabeth P. Dellon, Margaret W. Leigh, James R. Yankaskas, Terry L
Anne K. Swisher, Kathryn Moffett, Linda Baer 
Early aggressive eradication therapy for intermittent Pseudomonas aeruginosa airway colonization in cystic fibrosis patients: 15 years experience  C.R.
Presentation transcript:

Stigma and optimism in adolescents and young adults with cystic fibrosis  Kendea N. Oliver, Matthew L. Free, Cody Bok, Karen S. McCoy, Kathleen L. Lemanek, Charles F. Emery  Journal of Cystic Fibrosis  Volume 13, Issue 6, Pages 737-744 (December 2014) DOI: 10.1016/j.jcf.2014.04.005 Copyright © 2014 European Cystic Fibrosis Society. Terms and Conditions

Fig. 1 Distress by level of stigma and optimism. Interaction revealing that higher stigma and lower optimism were associated with elevated distress. For purposes of graphing the interaction, high levels of optimism and stigma were defined as one SD above the mean, while low levels were defined as one SD below the mean. Key: Distress=Hospital Anxiety and Depression Scale (HADS); Stigma=Social Impact Scale (SIS); Optimism=Life Orientation Test-Revised (LOT-R). Journal of Cystic Fibrosis 2014 13, 737-744DOI: (10.1016/j.jcf.2014.04.005) Copyright © 2014 European Cystic Fibrosis Society. Terms and Conditions

Fig. 2 Emotional functioning by level of stigma and optimism. Interaction revealing that higher stigma and lower optimism were associated with lower emotional functioning. For purposes of graphing the interaction, high levels of optimism and stigma were defined as one SD above the mean, while low levels were defined as one SD below the mean. Key: Emotional functioning=Emotional functioning domain of the Cystic Fibrosis Questionnaire-Revised (CFQ-R); Stigma=Social Impact Scale (SIS); Optimism=Life Orientation Test-Revised (LOT-R). Journal of Cystic Fibrosis 2014 13, 737-744DOI: (10.1016/j.jcf.2014.04.005) Copyright © 2014 European Cystic Fibrosis Society. Terms and Conditions